Anzeige
Mehr »
Login
Montag, 04.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
Sagenhafte +10.000 % Gewinnchance mit Spezialisten für KI-Cybersecurity!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PFQU | ISIN: US6748705067 | Ticker-Symbol: RUOC
Tradegate
04.11.24
20:41 Uhr
0,138 Euro
+0,004
+2,99 %
1-Jahres-Chart
OCEAN POWER TECHNOLOGIES INC Chart 1 Jahr
5-Tage-Chart
OCEAN POWER TECHNOLOGIES INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,0970,17823:00
0,1320,14122:00
ACCESSWIRE
533 Leser
Artikel bewerten:
(2)

Paragon Technologies Inc.: Ocean Power Fails to Engage in Good Faith with Paragon Creating Going Concern Issues and Risk for the Company and Its Shareholders

EASTON, PA / ACCESSWIRE / June 7, 2024 / Paragon Technologies, Inc. ("Paragon"), a diversified holding company and a large shareholder of Ocean Power Technologies, Inc. (NYSE American:OPTT), ("Company" or "OPT"), issues the following statement.

On April 28th Paragon announced its willingness to consider investing up to $3 million in non-dilutive preferred equity in OPT. In exchange for making this investment, Paragon put forward a general framework of terms customary for distressed investments. Paragon agreed to drop existing lawsuits pending against OPT should a suitable financing solution be agreed upon.

Despite the Company's precarious financial condition, the OPT Board has decided not to make a good faith effort to engage Paragon to discuss this potentially crucial investment instead making unreasonable demands of Paragon a condition for such discussions.

Instead of engaging with Paragon, OPT continues to issue press releases touting completed testing studies or partnerships that are vague and lack any substance as to the impact of these awards, contracts or results on OPT's operating performance which has been dismal. OPT CEO Phillip Stratmann continues to make optimistic remarks putting a positive spin on the announcements without quantifying their impact on the Company's future financial performance.

In an SEC filing on December 13, 2023, OPT's Board issued a statement that OPT would generate "positive cash flow in calendar year 2025 using current cash available" which also lacked any specificity that would create accountability for management or the Board in achieving this objective.

Over the past several weeks, while continuing to issue vague press releases, OPT trading volume has surged to millions of shares per today. We believe this increased volume reflects OPT initiating sales of millions of additional shares in the open market at punishing prices to raise cash that serves to only severely dilute existing shareholders. All of this occurred just months after OPT's CEO assured shareholders the Company had sufficient capital to achieve profitability.

In our opinion, shareholders should be concerned that Ocean Power is issuing these cryptic press releases in hopes of temporarily boosting the share price to support the equity sales necessary to raise cash for operations that management just months ago said would not be necessary to achieve positive cash flow.

The market has clearly not responded positively to any of OPT's news as the share price has continued to decline, down by approximately 50% over the past three months since the conclusion of the last annual meeting. OPT shares are now down over 90% since OPT's refreshed its Board and appointed Stratmann as CEO in 2021.

The refusal of OPT's Board to consider Paragon's offer of critical non-dilutive capital funding suggests that, rather than evaluate a viable financing option, Ocean Power's Board prefers to dilute existing shareholders to maintain their failed oversight of OPT's operations.

We invite Mr. Stratmann to communicate to shareholders now as directly as he did when soliciting their votes for the annual meeting when he painted what appears to have been an overly optimistic near-term outlook for OPT. Additionally, Stratmann should address:

1. Whether OPT is still expected to achieve cash flow positive and profitable operations in 2025.

2. Whether OPT has, in fact, been selling stock to raise capital only months after telling shareholders the Company would not need to take such action.

3. Quantifying the financial impact and timing of the revenue impact associated with each of the recent press releases purporting to demonstrate the success of the Company's products with respect to the Company's progress in achieving acceptable financial results.

We strongly believe in corporate transparency which we believe OPT lacks. Mr. Stratmann should provide shareholders with the full story, not just pieces that support his narrative. Shareholders are entitled to all the facts, not just positive spin.

Contact at ir@pgntgroup.com.

SOURCE: Paragon Technologies Inc.



View the original press release on accesswire.com

© 2024 ACCESSWIRE
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Diesen Artikel auf Deutsch lesen
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.